This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Wade Ackerman
Los Angeles +1 424 332 4763 Download V-card

Wade Ackerman served as Senior FDA Counsel to the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee until June 2016. In this role, he was intimately involved in legislative initiatives, oversight hearings, and other Senate activities concerning the FDA and the Federal Food, Drug, and Cosmetic Act, and he interacted extensively with legal, policy, and government relations staff at companies marketing products regulated by the FDA. He worked closely with the FDA and other stakeholders as Congress examined legislative reforms in key areas, including drug and device innovation, health software, diagnostics/LDTs, cosmetics, and over-the-counter drugs. Most recently, he negotiated FDA provisions in the Senate’s companion legislation to the “21st Century Cures Act,” which includes various provisions aimed at fostering innovation in the development and approval of new pharmaceuticals, biologics, and medical devices.

Previous Experience

  • U.S. Senate Committee on Health, Education, Labor, and Pensions, Senior FDA Counsel
  • U.S. Food and Drug Administration, Associate Chief Counsel